1.Expression and regulation of aquaporin 3 in human amnion epithelial cells
Xiaoyan MA ; Qi SHEN ; Jingjing WANG ; Ailan XIE ; Xueqiong ZHU
Chinese Journal of Perinatal Medicine 2013;(5):288-293
Objective To investigate the role of mitogen-activated protein kinases (MAPK)/extracellular signal regulated kinase1/2 (ERK1/2) signal transduction pathway in regulating the expression of aquaporin 3 (AQP3) in human amnion epithelial cells.Methods Primary cell culture of human amnion epithelial cells deriving from amnion of term pregnancy with normal amniotic fluid volume (AFV) or isolated oligohydramnios was conducted in the Second Affiliated Hospital of Wenzhou Medical College from January to November 2011.Either group included 10 elective cesarean cases.The primarily cultured cells were treated with different concentrations (0,5,10,20 and 40 mol/L) of ERK inhibitors (U0126) for 12 h,and then the optimal concentration of U0126 which resulted in the lowest expression of phospho~ERK1/2 (p-ERK1/2) was added for different durations(0,2,6,12 and 24 h).Immunocytochemistry was used to detect the localization of AQP3 and Western blot analysis was used to examine the expression of total ERK1/2,p-ERK1/2 and AQP3 in human amnion epithelial cells.Statistical analysis was performed by t-test and one-way ANOVA.Results (1) Compared with those in normal AFV group,p-ERK1/2 and AQP3 expression in human amnion epithelium cells decreased in oligohydramnios group,respectively (p-ERK1/2:3.46 ± 0.33 and 2.46±0.25;AQP3:2.34 ± 0.18 and 1.56±0.10,t=9.243 and 13.292,P<0.01).(2) In oligohydramnios groups,after treated with different concentrations of U0126,the expressions of total ERK1/2 did not change (F=0.365,P>0.05).The expression of p-ERK1/2 and AQP3 in 5,10,20,40 μmol/L U0126 (p-ERK1/2:0.96±0.16,1.12±0.13,0.98±0.17 and 1.02±0.26; AQP3:1.10±0.09,1.12±0.08,1.13±0.06 and 1.11±0.06) were all significantly lower than those in 0 μmol/LU0126 group (p-ERK1/2:2.46±0.25; AQP3:1.56±0.10,P<0.05).However,the expression of p-ERK1/2 and AQP3 showed no significant difference among 5,10,20,and 40μmol/L U0126 groups (P>0.05).The optimal concentration of U0126 was 5 μmol/L.After treated with 5 μmol/L U0126 for 2 h,the expressions of p-ERK1/2 and AQP3 (1.27±0.29 and 1.44±0.12)were lower than those after treated for 0 h (2.55±0.12 and 2.15±0.09,P<0.05).However,there was no significant difference among groups treated for 2,6,12 and 24 h.Therefore,the optimal treatment time was 2 h.(3) The expression of AQP3 was distributed in both cell membrane and cytoplasm in amnion epithelial cells with normal amniotic fluid volume or isolated oligohydramnios,but mainly in cytoplasm.U0126 did not change the localization of AQP3 expression.Conclusions U0126 inhibits the phosphorylation of ERK1/2 and expression of AQP3 of women with oligohydramnios,indicating that the MAPK/ERK1/2 signal transduction pathway might regulate the expression of AQP3 in human amnion epithelial cells,and therefore affect the balance of amniotic fluid volume.
2.Investigation on spoligotyping and phenotypes of drug resistance to four first-line drugs in 251 Mycobacterium tuberculosis isolates from Qinghai, China
Zhaofen WANG ; Bin LI ; Mingxia JIANG ; Yongcheng MA ; Haijing WANG ; Xiuli SHEN ; Xueqiong YAO ; Tingting LI ; Ying CHEN ; Xinhua WANG
Chinese Journal of Zoonoses 2017;33(4):332-336
This study aims to learn drug resistance situation of four first-line anti TB drugs among 251 Mycobacterium tuberculosis isolates from Qinghai and to explore their relationships with genotypes by Spoligotyping,so as to provide basis for effective prevention of tuberculosis.Isolates of 251 M.tuberculosis were tested susceptibilities of four first-line drugs including isoniazid (INH),rifampicin (RFP),streptomycin(SM) and ethambutol (EMB) by using conventional proportion method and genotyped by Spoligotyping.Relationship between drug resistance and genotypes was analyzed statistically.Results showed the total drug resistance rate was 56.2% (141/251) among 251 M.tuberculosis isolates.Resistance rates of four first-line drugs were 43.0% (108/251) for INH,37.1% (93/251) for RFP,39.0% (98/251) for SM,27.9% (70/251) for EMB respectively.Rate of multidrug-resistant TB (MDR TB) was 31.5% (79/251).All 251 isolates of M.tuberculosis were typed by spoligotyping.The 185 (73.7 %) were Beijing genotypes and 66 (26.3.%) were non-Beijing genotypes,and no statistical association was found with drug resistance.This paper concludes that isolates of M.tuberculosis prevail in Qinghai have both high rates of drug resistance and MDR and dominant isolates are Beijing genotypes by spoligotyping.
3.Identification of Xanthii Fructus and Its Adulterants Based on ITS2 Sequence
Jun WANG ; Xia LIU ; Yaqin ZHANG ; Ming SONG ; Yunhan LIN ; Xiaoxi MA ; Wei SUN ; Li XIANG ; Zhigang HU ; Lan WU ; Xueqiong ZHANG ; Weiyi HU
World Science and Technology-Modernization of Traditional Chinese Medicine 2014;(2):329-334
Objective: To identify Xanthii Fructus and secure its quality and safety in medication. Methods: Total ge-nomic DNA was extracted from Xanthii Fructus and its adulterants. ITS2 sequences were amplified, and purified PCR products were sequenced. Sequence assembly and consensus sequence generation were performed using the CodonCode Aligner V 4.2. The Kimura 2-Parameter (K2P) distances were calculated using MEGA 5.0. The neigh-bor-joining (NJ) phylogenetic trees were constructed. Results: The intraspecific genetic distances of Xanthii Fructus were 0. The interspecific genetic distances between Xanthii Fructus and its adulterants were ranged from 0.009 to 0.542. The NJ tree showed that Xanthii Fructus could differ from its adulterants obviously. Conclusion: ITS2 can be used to identify Xanthii Fructus from its adulterants effectively, and our study further confirmed the effectiveness of ITS2 to identify traditional Chinese medicinal materials.
4.Nutritional risk screening for elderly patients with colorectal cancer and its impact on infectious complications
Hui JIAO ; Yongjing DAI ; Teng MA ; Xueqiong MA
Chinese Journal of Postgraduates of Medicine 2024;47(10):940-944
Objective:To analyze the nutritional status of elderly patients with colorectal cancer and its impact on postoperative infectious complications.Methods:A retrospective collection was conducted on 782 colorectal cancer patients admitted to the First Medical Center of PLA General Hospital from June 2020 to June 2022. The nutritional status of the patients was screened, and they were divided into nutritional risk group (355 cases) and control group (427 cases) based on whether they had nutritional risk. The main clinical characteristics and postoperative recovery of the two groups were compared. The predictive value of nutritional related indicators for postoperative infectious complications was also analyzed.Results:Univariate analysis showed that age, tumor invasion of intestinal wall muscle layer and decreased serum albumin were risk factors for nutritional risk in elderly patients with colorectal cancer ( P<0.05). The results of multivariate factor analysis showed that age≥75 years old was an independent risk factor for nutritional risk in elderly patients with colorectal cancer ( RR = 1.990, 95% CI 1.402 - 2.825, P<0.01). Compared with the control group, patients in the nutrition risk group had longer hospital stay and an increased incidence of postoperative complications: (13.59 ± 8.20) d vs. (11.91 ± 5.04) d, 16.34%(58/355) vs. 6.09%(26/427), there were statistical differences ( P<0.05). The results of multivariate factor analysis showed that elderly nutrition risk index<98, preoperative chemotherapy were risk factors for infectious complications in colorectal cancer patients ( RR = 2.982, 95% CI 1.818 - 4.890, P<0.01; RR = 2.759, 95% CI 1.119 - 6.799, P<0.05). Conclusions:The proportion of elderly patients with colorectal cancer who have nutritional risk is relatively high, and age is the main factor leading to nutritional risk. Nutritional risk can lead to an increase in postoperative infectious complications.
5.Development of a diagnosis model for active pulmonary tuberculosis using mass spectrometry and pro-tein chip
Xueqiong WU ; Junxian ZHANG ; Yan LIANG ; Mei DONG ; Bin YI ; Ruijuan MA ; Hua WEI ; Jianqin LIANG ; Yourong YANG ; Hongbing CHEN ; Cuiying ZHANG ; Jufang HE ; Hong WU ; Zhongxing LI ; Youning LIU
Chinese Journal of Microbiology and Immunology 2008;28(11):1040-1043
Objective To develop a diagnosis model for active pulmonary tuberculosis. Methods The proteomic fingerprinting of 264 sera from active tuberculosis patients and controls were analyzed using the surface-enhanced laser desorption ionization time of flight mass spectrometry (SELDI-TOF-MS) and protein-chip technology. The peaks were detected and filtrated by Ciphergen PrnteinChip(R) Software (version 3.1.1). Using the Biomarker Pattern 5.0 software, a diagnostic model was developed for diagnosis of active tuberculosis. Re-sults Fifty protein peaks were significantly different between the patients with active pulmonary tuberculosis and the controls with overlapping clinical features (P<0.01). Five protein peaks at 4360, 3311, 8160, 5723, 15173 m/z were chosen for the system classifier and the development of diagnosis model 1. The model differenti-ated the patients with active pulmonary tuberculosis from the controls with a sensitivity of 83.0%, and a speci-ficity of 89.6%. The diagnostic accuracy was up to 86.4%. Three protein peaks at 5643, 4486, 4360 m/z were chosen for the system classifier and the development of diagnosis model 2. The model differentiated the pa-tients with active pulmonary tuberculosis from the controls with a sensitivity of 96.9%, and a specificity of 97.8%. The diagnostic accuracy was up to 97.3%. Conclusion It might be a new diagnostic test for the de-tection of sera from the patients with active pulmonary tuberculosis using SELDI-TOF-MS and protein chip.